1X10^6 human PBMCs were surface co-stained with CL488 Anti-Human CD19 and 5 ul APC Anti-Human CD3 (APC-65151, Clone:UCHT1) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul APC Anti-Human CD3 (APC-65151, Clone:UCHT1) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with FITC Anti-Human CD19 and 0.2 ug Anti-Human CD3 (65151-1-Ig, Clone:UCHT1) labeled with FlexAble CoraLite® Plus 647 Antibody Labeling Kit for Mouse IgG1 or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 0.2 ug Anti-Human CD3 (65151-1-Ig, Clone:UCHT1) labeled with FlexAble CoraLite® Plus 647 Antibody Labeling Kit for Mouse IgG1 or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with CL647 Anti-Human CD19 and 5 ul Atlantic Blue™ Anti-Human CD3 (AB-65151, Clone: UCHT1) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul Atlantic Blue™ Anti-Human CD3 (AB-65151, Clone: UCHT1) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with Atlantic Blue Anti-Human CD19 and 5 ul Cardinal Red™ Anti-Human CD3 (CR-65151, Clone:UCHT1) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul Cardinal Red™ Anti-Human CD3 (CR-65151, Clone:UCHT1) (red) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with FITC Anti-Human CD19 and 5 ul CoraLite® Plus 405 Anti-Human CD3 (CL405-65151, Clone: UCHT1) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 405 Anti-Human CD3 (CL405-65151, Clone: UCHT1) (red) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with CL647 plus CD19 and 5 ul CoraLite® Plus 488 Anti-Human CD3 (CL488-65151, Clone:UCHT1) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 488 Anti-Human CD3 (CL488-65151, Clone:UCHT1) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with CL647 Anti-Human CD19 and 5 ul CoraLite® Plus 555 Anti-Human CD3 (CL555-65151, Clone:UCHT1) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 555 Anti-Human CD3 (CL555-65151, Clone:UCHT1) (red) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with FITC Anti-Human CD19 and 5 ul CoraLite® Plus 647 Anti-Human CD3 (CL647-65151, Clone: UCHT1) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 647 Anti-Human CD3 (CL647-65151, Clone: UCHT1) (red) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---